WhyPeptides

ClinicalTrials.gov research-record information

ClinicalTrials.gov research records

ClinicalTrials.gov research-record snapshot for Omaha, NE

Snapshot scope: This page is a static ClinicalTrials.gov research-record snapshot retrieved on . The fixed source query returned 7 results; after an exact city/state check of listed facilities, 7 records were retained for Omaha, Nebraska. It is not a clinic, enrollment, or local-availability directory.

Snapshot methodology and exact-location matching

City/state source filter
Omaha, Nebraska
Exact-location inclusion rule
A listed facility city and state must match Omaha, Nebraska.

Records are retained only after the listed facility location matches the fixed city and state. This location match does not establish enrollment, site activity, eligibility, or local availability.

Fixed query terms

  • semaglutide
  • tirzepatide
  • cagrilintide
  • retatrutide
  • tesamorelin
  • sermorelin
  • ipamorelin
  • bpc-157
  • thymosin alpha 1
  • pt-141

Included study statuses

  • RECRUITING
  • NOT_YET_RECRUITING
  • ACTIVE_NOT_RECRUITING
  • ENROLLING_BY_INVITATION

How to read this snapshot

Research-record limits

All retained records

Study-level status mix

The counts below summarize every retained record in this snapshot. They describe registry study status only, not whether a particular facility is enrolling.

RECRUITING
1 record
NOT_YET_RECRUITING
1 record
ACTIVE_NOT_RECRUITING
5 records
ENROLLING_BY_INVITATION
0 records

Records in this snapshot

Retained ClinicalTrials.gov NCT records

The retrieved source snapshot contains 7 exact-location records and 8 listed facilities. All 7 retained records are shown below.

NCT04822181

Registry title: Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Univ of Nebraska Medical CTROmaha, Nebraska 68198-3020

NCT07505303

Registry title: MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Velocity Clinical Research (3345 N 107th St) - Omaha - Nebraska - PPDSOmaha, Nebraska 68134

NCT07662213

Registry title: A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Study-level overall status
NOT_YET_RECRUITING
Record update date

Exact-matched listed facility/location

  • Research SiteOmaha, Nebraska 68114

NCT06534411

Registry title: A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • Univ of Nebraska Medical CTROmaha, Nebraska 68198-3020

NCT05669755

Registry title: REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • VA Neb West Iowa Hlth SystemOmaha, Nebraska 68105
  • Methodist Physicians ClinOmaha, Nebraska 68114
  • Univ of NE Med Center_OmahaOmaha, Nebraska 68198-6828

NCT05390892

Registry title: PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

Study-level overall status
RECRUITING
Record update date

Exact-matched listed facility/location

  • University of Nebraska Medical CenterOmaha, Nebraska 68198

NCT05556512

Registry title: A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date

Exact-matched listed facility/location

  • VA Nebraska-Western Iowa Health Care SystemOmaha, Nebraska 68105

Source retrieval and snapshot limits

Source-query results versus exact-location records

At retrieval, the fixed ClinicalTrials.gov source query returned 7 results. After an exact city/state check of listed facilities, 7 records were retained for Omaha, Nebraska, across 8 listed facilities. All 7 retained records are shown on this page.

Source retrieved
Record update dates
Shown for each displayed NCT record, as supplied by ClinicalTrials.gov
Source-query results
7
Exact-location records retained
7
Listed facilities retained
8
Records shown
7 of 7
Fixed ClinicalTrials.gov source query (JSON) Broader live ClinicalTrials.gov search (no status filter)

Live search scope: This broader live search does not reproduce the included-status filter used for this snapshot, so it can show other study statuses and change after source retrieval.

Snapshot limits: The retrieval timestamp records when Why Peptides retrieved the ClinicalTrials.gov source query; it is not an independent validation. Record update dates are supplied by ClinicalTrials.gov and can differ from the retrieval timestamp. This static snapshot is not a complete or live catalog and can become stale. Why Peptides has not independently validated record details, facilities, enrollment, contacts, eligibility, or site status. For a displayed study, open its linked ClinicalTrials.gov NCT record for current contacts, eligibility, and site status.